IDWeek 2024
Biktarvy’s Benefits Extend in Older Adults With HIV
Five-year follow-up data from the triple combination HIV therapy bictegravir-emtricitabine-tenofavir alafenamide ...
NOVEMBER 26, 2024
CNS Involvement in Immunocompromised Shingles Patients: Don’t Miss the Subtle Signs
A retrospective case series study of immunocompromised patients with active herpes zoster infections who presented ...
NOVEMBER 21, 2024
Improving HBV Screening Before Switching to 2-Drug HIV Regimens
Implementation of a best-practice alert in the EHR led to a significant decrease in switches to two-drug ART among ...
NOVEMBER 11, 2024
Negative Results on BioFire Pneumonia Panel Allow Antibiotic Discontinuation
A rapid multiplexed molecular panel facilitated safe discontinuation of antibiotic therapy in patients with ...
OCTOBER 25, 2024
Preset Treatment Orders Improve Pediatric Antibiotic Prescribing Practices
Including preset treatment orders in the EHRs improved compliance with treatment guidelines and shortened ...
OCTOBER 17, 2024
Tennessee’s Rejection of CDC HIV Funds Will Lead to Increased Transmissions and Deaths, Expert Warns
Tennessee’s decision to reject more than $6 million in CDC funding for HIV prevention, detection and ...
OCTOBER 17, 2024
